Literature DB >> 3561530

Effects of bile acids on ventricular muscle contraction and electrophysiological properties: studies in rat papillary muscle and isolated ventricular myocytes.

O Binah, I Rubinstein, A Bomzon, O S Better.   

Abstract

The effects of sodium salts of various bile acids on the contractile force and the electrophysiological properties of rat ventricular muscle were studied in vitro. Primary, conjugated, and secondary bile acids were studied in a concentration range of 10(-9)-10(-6) mol/l, which corresponds to concentrations found in the plasma of patients with cholestatic jaundice. In general, the bile acid induced a negative inotropic effect which was manifested as a reduction in active tension, maximum rate of tension activation, and maximum rate of tension relaxation. Twitch duration and time to peak tension were unaffected by the bile acids. The negative inotropism was associated with a reduction in ventricular action potential duration. Resting potential, action potential amplitude, and maximum upstroke velocity of phase 0 depolarization were unaffected. Voltage clamp experiments in rat ventricular myocytes demonstrated that sodium taurocholate decreased the slow inward current and slightly increased the outward potassium current. Hence, these effects on the membrane currents are probably responsible for the negative inotropic effect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3561530     DOI: 10.1007/BF00177718

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases.

Authors:  I Makino; S Nakagawa; K Mashimo
Journal:  Gastroenterology       Date:  1969-06       Impact factor: 22.682

2.  Spontaneously active cells isolated from the sino-atrial and atrio-ventricular nodes of the rabbit heart.

Authors:  J Taniguchi; S Kokubun; A Noma; H Irisawa
Journal:  Jpn J Physiol       Date:  1981

3.  Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium".

Authors:  G Isenberg; U Klockner
Journal:  Pflugers Arch       Date:  1982-10       Impact factor: 3.657

4.  Changes in the binding of radioactive conjugated bile salts to serum proteins in cholestatic jaundice.

Authors:  A Chitranukroh; B H Billing
Journal:  Clin Sci (Lond)       Date:  1983-07       Impact factor: 6.124

5.  The effect of jaundiced sera and bile salts on cultured beating rat heart cells.

Authors:  E Bogin; O Better; I Harari
Journal:  Experientia       Date:  1983-11-15

6.  Sinus bradycardia in obstructive jaundice--correlation with total serum bile acid concentrations.

Authors:  E Song; I Segal; J Hodkinson; M C Kew
Journal:  S Afr Med J       Date:  1983-09-28

7.  Jaundice, the circulation and the kidney.

Authors:  J Green; R Beyar; L Bomzon; J P Finberg; O S Better
Journal:  Nephron       Date:  1984       Impact factor: 2.847

8.  Similarities and differences between models of extrahepatic biliary obstruction and complete biliary retention without obstruction in the rat.

Authors:  W G Hardison; R G Weiner; D E Hatoff; K Miyai
Journal:  Hepatology       Date:  1983 May-Jun       Impact factor: 17.425

9.  Cholic acid and the heart: in vitro studies of the effect on heart rate and myocardial contractility in the rat.

Authors:  P Joubert
Journal:  Clin Exp Pharmacol Physiol       Date:  1978 Jan-Feb       Impact factor: 2.557

10.  Enhancement of the urinary excretion of non-sulphated and sulphated radioactive bile acids by sodium acetate in the bile duct obstructed rat.

Authors:  A Chitranukroh; G Taggart; B H Billing
Journal:  Clin Sci (Lond)       Date:  1985-01       Impact factor: 6.124

View more
  19 in total

Review 1.  Bile acids regulate cardiovascular function.

Authors:  Sandeep Khurana; Jean-Pierre Raufman; Thomas L Pallone
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

2.  Effect of bile acid on electrophysiological properties of rabbit sino-atrial node in vitro.

Authors:  H Kotake; T Itoh; M Watanabe; I Hisatome; J Hasegawa; H Mashiba
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

3.  Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis.

Authors:  Moreshwar S Desai; Zeena Eblimit; Sundararajah Thevananther; Astrid Kosters; David D Moore; Daniel J Penny; Saul J Karpen
Journal:  Liver Int       Date:  2014-01-12       Impact factor: 5.828

4.  Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart.

Authors:  Moreshwar S Desai; Bhoomika Mathur; Zeena Eblimit; Hernan Vasquez; Heinrich Taegtmeyer; Saul J Karpen; Daniel J Penny; David D Moore; Sayeepriyadarshini Anakk
Journal:  Hepatology       Date:  2016-11-29       Impact factor: 17.425

Review 5.  Arrhythmia risk in liver cirrhosis.

Authors:  Ioana Mozos
Journal:  World J Hepatol       Date:  2015-04-08

6.  On the in vitro vasoactivity of bile acids.

Authors:  P Ljubuncic; O Said; Y Ehrlich; J B Meddings; E A Shaffer; A Bomzon
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

7.  Role of Na+/Ca++ exchange in the relaxant effect of sodium taurocholate on the guinea-pig ileum smooth muscle.

Authors:  F Romero; E Frediani-Neto; T B Paiva; A C Paiva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

8.  Bile acids induce arrhythmias: old metabolite, new tricks.

Authors:  Moreshwar S Desai; Daniel J Penny
Journal:  Heart       Date:  2013-08-22       Impact factor: 5.994

9.  Mechanism of bile salt vasoactivity: dependence on calcium channels in vascular smooth muscle.

Authors:  J M Pak; A S Adeagbo; C R Triggle; E A Shaffer; S S Lee
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

Review 10.  Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review.

Authors:  Petra Mamic; Thanat Chaikijurajai; W H Wilson Tang
Journal:  J Mol Cell Cardiol       Date:  2020-12-09       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.